1. Published Name of the Standard for which request is being made (if previously published)

 HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1- US Realm

2. Standards Material/Document

 Informative

3. Date of Request

 Feb 27, 2023

4. Use Period

5. Reason for extension, timeline, and actions

6. Original Publication Date

7. End date of the current STU period

8. Length of the requested extension

9. Review Process

10. HL7 Work Group making this request and date

 Pharmacy

10a. Requesting WG Date

 Feb 27, 2023

11. URL of approval minutes

 https://confluence.hl7.org/pages/viewpage.action?pageId=156545329

12. HL7 Product Management Group

12a. Management Group Date of Approval

13. URL of approval minutes

14. Is the artifact ready for final publication?

 Yes

15. If not ready, please describe remaining steps.

16. Tool name used to produce the machine processable artifacts in the IG

 not applicable

17. The name of the “IG artifact” within the context of the above mentioned tool.

not applicable

18. Balloted Name of the standard for which request is being made

 HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1- US Realm

19. Requested name for published standard. See Naming Examples

 HL7/NCPDP Informative Document: Pharmacist Consultation Note, Release 1

19a. Specification Feedback Name (For Search in Jira)

20. If CMET, list IDs balloted

21. Project Insight Number

 1743

22. Document Realm

 US Realm

23. Ballot cycle in which the document was successfully balloted

 2022-09

25. Affirmative

 58

26. Negative

 1

27. Abstentions

 45

28. Not Returned

 39

29. Total in ballot pool

 134

30. Date on which final document/standards material was supplied to HQ

Feb 27, 2023

31. URL of publication material/ SVN repository

 https://confluence.hl7.org/download/attachments/79512445/20230226%20Pharmacist%20Consultation%20Note%20for%20publication.docx?version=1&modificationDate=1677520664743&api=v2

32. Publishing Facilitator

 Scott Robertson

33. Special Publication Instructions

34. URL of ballot reconciliation document

 http://www.hl7.org/documentcenter/public/ballots/2022SEP/reconciliation/recon_hl7_pharm_consult_r1_i1_2022sep.xls

35. Has the Work Group posted its consideration of all comments received in its reconciliation document on the ballot desktop?

 Yes

36. Substantive Changes Since Last Ballot?

 No

37. Product Brief Reviewed By

 Pharmacy WG

38. Date Product Brief Reviewed

 Feb 27, 2023

39. Has the Product Brief changed?

40. Family

 Cross-Paradigm

41. Section

 Clinical and Administrative Domains, Implementation Guides

42. Topic

 Pharmacy

43. Please Describe the Topic

 Guidance on the use of C-CDA Consultation Note and C-CDA on FHIR for a Pharmacist Consultation Note

44. Product Type

 Document

45. Parent standard

 HL7 Implementation Guide for CDA® Release 2: Consolidated CDA Templates for Clinical Notes (US Realm) Standard for Trial Use Release 2.1

C-CDA on FHIR 1.1.0 - (FHIR R4) STU Release 1.1 Consultation Note Profile

46. Parent Standard Status

 Active

47. Update/replace standard

 supplemental

48. Common name/search keyword

 pharmacy consult note, pharmacist consult note, consultant pharmacist consultation note

49. Description

50. Stakeholders

51. Vendors

 Health Care IT

52. Providers

 Healthcare Institutions (hospitals, long term care, home care, mental health)

53. Benefits

54. Implementations/Case Studies

55. Development Background